Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cubert is a German hyperspectral imaging company that develops and sells compact snapshot hyperspectral cameras and analysis software for research, industrial, and medical applications. The company’s core offering is a real-time hyperspectral imaging platform built around proprietary snapshot camera systems and its CUVIS software suite, including CUVIS AI for machine-learning-enabled analysis. In healthcare, Cubert positions its technology for non-invasive medical imaging, clinical studies, image-based diagnostics, intraoperative visualization, and pharmaceutical research workflows. Its systems are used to analyze tissue, lesions, blood flow, cellular responses, and other spectral signatures without contact and in real time. Cubert appears to be primarily a commercial instrumentation and platform company rather than a therapeutics developer, with revenue generated from cameras, software, and customized solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cubert.